Tag: ODC inhibitor therapy

Home / ODC inhibitor therapy

Categories

Eflornithine is approved by USFDA for adult and pediatric patients with high-risk neuroblastoma

The FDA approved eflornithine (IWILFIN, USWM, LLC) on December 13, 2023, to lower the risk of relapse in adults and children with high-risk neuroblastoma (HRNB) who had a partial response to previou...
odc-inhibitor-therapy

Scan the code